[Federal Register Volume 75, Number 10 (Friday, January 15, 2010)]
[Notices]
[Page 2549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-730]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities; Office of Science Policy; 
Office of the Director; Notice of a Meeting of the NIH Blue Ribbon 
Panel

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University 
Medical Center.
    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Diseases 
Laboratories (NEIDL) at Boston University Medical Center. The meeting 
will be held on Friday, February 12, 2010, at the Hyatt Regency 
Bethesda Hotel, located at 7400 Wisconsin Avenue, Bethesda, Maryland 
20814, from approximately 8:30 a.m. to 2 p.m. This meeting is the 
second in a series of public meetings with the National Research 
Council to review the ongoing supplementary risk assessment study.
    Sign up for public comment will begin at approximately 8 a.m. In 
the event that time does not allow for all those interested in 
presenting oral comments, anyone may file written comments using the 
following address below.
    An agenda and slides for the meeting can be obtained prior to the 
meeting by connecting to http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information concerning this meeting, 
contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of 
Biotechnology Activities, Office of Science Policy, Office of the 
Director, National Institutes of Health, 6705 Rockledge Drive, Room 
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail 
[email protected].

    Dated: January 11, 2010.
Kelly R. Fennington,
Special Assistant to the Director, Office of Biotechnology Activities, 
National Institutes of Health.
[FR Doc. 2010-730 Filed 1-14-10; 8:45 am]
BILLING CODE 4140-01-P